Synthomer plc (LON:SYNT – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 243.55 ($3.07) and traded as low as GBX 170 ($2.14). Synthomer shares last traded at GBX 174 ($2.19), with a volume of 241,692 shares changing hands.
Analysts Set New Price Targets
Several research firms have recently commented on SYNT. Canaccord Genuity Group reduced their target price on Synthomer from GBX 300 ($3.78) to GBX 275 ($3.47) and set a “buy” rating for the company in a research note on Friday, October 4th. Berenberg Bank dropped their price target on Synthomer from GBX 375 ($4.73) to GBX 340 ($4.28) and set a “buy” rating on the stock in a research report on Tuesday, August 13th.
Get Our Latest Analysis on Synthomer
Synthomer Price Performance
Synthomer Company Profile
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
See Also
- Five stocks we like better than Synthomer
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Calculate Options Profits
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Stock Market Sectors: What Are They and How Many Are There?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.